Benzinga’s Top Upgrades (VQ, JOYG, TIBX, GSK, SYT)

Venoco Inc VQ was upgraded by Wells Fargo from “market perform” to “outperform.” VQ’s shares closed at $13.83 yesterday. Venoco is likely to earn 87.98% this year. Goldman Sachs upgraded Joy Global Inc JOYG from “neutral” to “buy.” JOYG’s shares closed at $48.44 yesterday. Joy Global’s earnings have grown 57.18% over the past 5 years. Goldman Sachs upgraded Tibco Software Inc TIBX from “sell” to “neutral.” TIBX closed at $11.18 yesterday. Tibco Software’s quarterly earnings jumped 87.89%. Analysts at Jefferies & Co upgraded GlaxoSmithKline plc GSK from “hold” to “buy.” GSK’s shares closed at $33.66 yesterday. GlaxoSmithKline’s trailing-twelve-month gross margin is 73.94%, Syngenta SYT has been upgraded to “outperform” from “neutral” by Credit Suisse. SYT’s shares closed at $43.91 yesterday. Syngenta’s quarterly earnings moved up 89.52%. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Long IdeasNewsUpgradesMarketsAnalyst RatingsTrading IdeasApplication SoftwareConstruction & Farm Machinery & Heavy TrucksEnergyFertilizers & Agricultural ChemicalsHealth CareIndustrialsInformation TechnologyMaterialsOil & Gas Exploration & ProductionPharmaceuticalstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!